Riga, Latvia

Maksim Vorona



 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Maksim Vorona

Introduction

Maksim Vorona is a notable inventor based in Riga, Latvia. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 2 patents, Vorona's work showcases his dedication to advancing medical science.

Latest Patents

Vorona's latest patents include the invention of N-carbamoylmethyl-4-(R)-phenyl-2-pyrrolidinone, which is recognized for its pharmacological value. This invention relates specifically to the R-enantiomer of N-carbamoylmethyl-4-phenyl-2-pyrrolidinone, also known as R-Carphedon. The method of preparation involves the N-alkylation of 4(R)-phenyl-2-pyrrolidinone with ethyl bromoacetate in the presence of a strong base. Additionally, the treatment of the intermediate N-ethoxycarbonylmethyl-4(R)-phenyl-2-pyrrolidinone with ammonia is a crucial step in the process.

Career Highlights

Throughout his career, Vorona has worked with prominent companies such as Olainfarm, a well-known pharmaceutical manufacturer in Latvia. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in the industry.

Collaborations

Maksim Vorona has collaborated with talented individuals such as Grigory Veinberg and Liga Zvejniece. These partnerships have fostered a creative environment that has led to innovative solutions in pharmaceutical development.

Conclusion

Maksim Vorona's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the industry positively, showcasing the importance of innovation in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…